Browse treatments

…ern Cooperative Oncology Group performance status, a history of chemotherapy within 1 month prior to admission and gastrointestinal malignan…

…romise the efficacy of conventional treatments like surgery and chemotherapy.Methods This study developed a multifunctional nanotherapeutic …

… NSCLC, treated with anti-programmed cell death protein 1 ICB (±chemotherapy) were included in this multicenter study (N=210 patients). PBMC…

…vanced gastric or gastroesophageal junction adenocarcinoma with chemotherapy. This first-in-class milestone revisits a key question raised b…

…s and a locally advanced tumour at the hepatic hilum, requiring chemotherapy. All cases expressed chromogranin A and synaptophysin. BTNETs w…

…ients (OAC=1; SCC=1; gastric adenocarcinoma=1), two of whom had chemotherapy and surgery.There was a trend towards higher rate of metastatic…

…settings for mid- to long-term intravenous therapies, including chemotherapy and antibiotics. However, their use involves risks such as infe…

…sis and hepatic dysfunction. Management is primarily focused on chemotherapy and symptomatic management of cholestatic liver failure. We des…

… resource intensive systemic treatments such as chemotherapy or immunomodulatory therapy.…

…lockers appear to confer modest cardioprotective effects during chemotherapy, particularly regarding systolic function and heart failure inc…

…ss ICC progression and significantly enhance the sensitivity to chemotherapy.Conclusions Our findings establish SIRT6 as an oncogenic driver…

…otal mastectomy and axillary lymph node dissection, followed by chemotherapy, radiotherapy, and hormone therapy between 2008 and 2016, with …